SPARCL1_Sc1 Activators
SPARCL1 Activators are a series of chemical compounds that enhance the functional activity of SPARCL1 through modulation of various signaling pathways. Forskolin, Rolipram, and 8-Br-cAMP work through the elevation of cAMP levels, leading to the activation of PKA, which may phosphorylate proteins that interact with SPARCL1, thereby enhancing its role in cell-matrix adhesion. L-Arginine, through the production of nitric oxide, also contributes to this cAMP-mediated pathway. In a similar vein, Sildenafil's inhibition of phosphodiesterase 5 indirectly raises cAMP levels, further potentiating SPARCL1's involvement in cell-matrix interaction. The activators A23187 and Ionomycin, by increasing intracellular calcium, activate calcium-dependent protein kinases, which might phosphorylate substrates that interact with SPARCL1, enhancing its adhesion functions.
Furthermore, Y-27632 and Blebbistatin, by modifying the cytoskeleton and cell contractility, provide a conducive extracellular environment for SPARCL1's action in cell adhesion. ML-7's inhibition of myosin light chain kinase similarly affects the cytoskeleton dynamics, potentially enhancing SPARCL1's role in the extracellular matrix. N6-Cyclopentyladenosine's agonistic effect on the adenosine A1 receptor increases cAMP levels, leading to the activation of PKA and subsequent enhancement of SPARCL1 activity in cell migration and adhesion. Lastly, Methylene Blue's role as a guanylate cyclase inhibitor alters cGMP and cAMP levels, which may further promote the phosphorylation activities of PKA, aiding in the enhancement of SPARCL1's function in cell adhesion and interaction with the extracellular matrix.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram is a selective inhibitor of phosphodiesterase 4, which prevents cAMP breakdown, indirectly enhancing cAMP-dependent pathways that include PKA activation. PKA can then phosphorylate targets that affect SPARCL1's role in cell adhesion and migration. | ||||||
L-Arginine | 74-79-3 | sc-391657B sc-391657 sc-391657A sc-391657C sc-391657D | 5 g 25 g 100 g 500 g 1 kg | $20.00 $31.00 $61.00 $219.00 $352.00 | 2 | |
L-Arginine serves as a substrate for nitric oxide synthase, leading to the production of nitric oxide (NO). NO can elevate cAMP levels, similarly leading to PKA activation. This can enhance SPARCL1-mediated modulation of cell adhesion. | ||||||
8-Bromoadenosine 3′,5′-cyclic monophosphate | 23583-48-4 | sc-217493B sc-217493 sc-217493A sc-217493C sc-217493D | 25 mg 50 mg 100 mg 250 mg 500 mg | $108.00 $169.00 $295.00 $561.00 $835.00 | 2 | |
8-Br-cAMP is a cAMP analog that resists degradation and activates PKA. PKA then can phosphorylate proteins that interact with SPARCL1, which is known to be involved in cell adhesion, thus potentially enhancing its function. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is a calcium ionophore that raises intracellular calcium levels, activating calcium-dependent protein kinases which could enhance SPARCL1's role in cell adhesion and migration through phosphorylation of associated proteins. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is another calcium ionophore that can increase intracellular calcium, potentially enhancing the activity of calcium-dependent kinases that phosphorylate substrates which may cooperate with SPARCL1 in extracellular matrix interactions. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 is a ROCK inhibitor that can lead to actin cytoskeleton rearrangements, which may promote SPARCL1-mediated cell adhesion by affecting the extracellular matrix structure that SPARCL1 interacts with. | ||||||
(S)-(−)-Blebbistatin | 856925-71-8 | sc-204253 sc-204253A sc-204253B sc-204253C | 1 mg 5 mg 10 mg 25 mg | $72.00 $265.00 $495.00 $968.00 | ||
Blebbistatin inhibits myosin II ATPase activity, leading to altered cell contractility and adhesion. This can promote SPARCL1's role in cell-matrix adhesion by affecting the extracellular matrix and cell shape. | ||||||
ML-7 hydrochloride | 110448-33-4 | sc-200557 sc-200557A | 10 mg 50 mg | $91.00 $267.00 | 13 | |
ML-7 is an inhibitor of myosin light chain kinase, which affects cytoskeleton dynamics and cell adhesion. Altering the cytoskeletal dynamics can enhance the role of SPARCL1 in cell-matrix adhesion by modulating the extracellular environment. | ||||||
N6-Cyclopentyladenosine | 41552-82-3 | sc-204117 | 50 mg | $120.00 | 2 | |
N6-Cyclopentyladenosine is an adenosine A1 receptor agonist, which can increase cAMP levels, leading to PKA activation and possible enhancement of SPARCL1 function in modulating cell adhesion and migration. | ||||||
Methylene blue | 61-73-4 | sc-215381B sc-215381 sc-215381A | 25 g 100 g 500 g | $43.00 $104.00 $328.00 | 3 | |
Methylene Blue acts as a guanylate cyclase inhibitor, which can affect cGMP and cAMP levels and thus enhance PKA activity. This in turn could promote the function of SPARCL1 in cell adhesion and extracellular matrix interactions. | ||||||